IDR 174.0
(-1.69%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -3.34 IDR | -18.44% |
2022 | -2.82 IDR | -1666.67% |
2021 | 0.18 IDR | -58.14% |
2020 | 0.43 IDR | 158.9% |
2019 | -0.73 IDR | 12.05% |
2018 | -0.83 IDR | -137.14% |
2017 | -0.35 IDR | -212.9% |
2016 | 0.31 IDR | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q3 | -0.72 IDR | -2.86% |
2024 Q1 | -0.66 IDR | -10.0% |
2024 Q2 | -0.70 IDR | -6.06% |
2023 Q4 | -0.60 IDR | 60.78% |
2023 FY | - IDR | -18.44% |
2023 Q3 | -1.53 IDR | -537.5% |
2023 Q2 | -0.24 IDR | 75.26% |
2023 Q1 | -0.97 IDR | -136.59% |
2022 FY | - IDR | -1666.67% |
2022 Q3 | -0.85 IDR | 6.59% |
2022 Q2 | -0.91 IDR | -40.0% |
2022 Q1 | -0.65 IDR | -71.05% |
2022 Q4 | -0.41 IDR | 51.76% |
2021 Q1 | 0.29 IDR | 192.04% |
2021 FY | - IDR | -58.14% |
2021 Q4 | -0.38 IDR | -528.89% |
2021 Q3 | 0.09 IDR | -50.78% |
2021 Q2 | 0.18 IDR | -37.93% |
2020 Q1 | -0.03 IDR | 66.51% |
2020 FY | - IDR | 158.9% |
2020 Q4 | 0.10 IDR | -29.07% |
2020 Q3 | 0.14 IDR | -46.15% |
2020 Q2 | 0.26 IDR | 1038.63% |
2019 Q2 | -0.21 IDR | 0.0% |
2019 Q1 | -0.21 IDR | 0.0% |
2019 FY | - IDR | 12.05% |
2019 Q4 | -0.08 IDR | 72.43% |
2019 Q3 | -0.30 IDR | -42.86% |
2018 FY | - IDR | -137.14% |
2017 FY | - IDR | -212.9% |
2016 FY | - IDR | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
PT Bundamedik Tbk | 0.87 IDR | 483.908% |
PT Medikaloka Hermina Tbk | 30.16 IDR | 111.074% |
PT Mitra Keluarga Karyasehat Tbk | 65.08 IDR | 105.132% |
PT Murni Sadar Tbk | -6.20 IDR | 46.129% |
PT Famon Awal Bros Sedaya Tbk | 15.54 IDR | 121.493% |
PT Royal Prima Tbk | -0.81 IDR | -312.346% |
PT Kedoya Adyaraya Tbk | 27.09 IDR | 112.329% |
PT Sarana Meditama Metropolitan Tbk | 0.71 IDR | 570.423% |
PT Siloam International Hospitals Tbk | 93.27 IDR | 103.581% |
PT Sejahteraraya Anugrahjaya Tbk | -3.21 IDR | -4.05% |